View in EDS HTML Full Text PDF Full Text

Clinical outcomes of modified busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for T-cell acute lymphoblastic leukemia/lymphoma.

Saved in:
Bibliographic Details
Title: Clinical outcomes of modified busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for T-cell acute lymphoblastic leukemia/lymphoma.
Authors: Guo J; School of Medicine, Nankai University, Tianjin, China., Li M; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China., Zhang L; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China., Zhang Q; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.; Medical School of Chinese PLA, Beijing, China., Wang N; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China., Wei Y; School of Medicine, Nankai University, Tianjin, China., Wei X; School of Medicine, Nankai University, Tianjin, China., Zhang X; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.; Medical School of Chinese PLA, Beijing, China., Wang X; School of Medicine, Nankai University, Tianjin, China., Li Y; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.; Medical School of Chinese PLA, Beijing, China., Wang L; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China., Li F; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China., Wang L; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China., Jing Y; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China., Bo J; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China., Dou L; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China., Liu D; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China., Gu Z; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China., Gao C; School of Medicine, Nankai University, Tianjin, China.; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Feb; Vol. 67 (3), pp. 685-698. Date of Electronic Publication: 2026 Jan 05.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41489116
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical outcomes of modified busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for T-cell acute lymphoblastic leukemia/lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Guo+J%22">Guo J</searchLink>; School of Medicine, Nankai University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Q%22">Zhang Q</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.; Medical School of Chinese PLA, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+N%22">Wang N</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wei+Y%22">Wei Y</searchLink>; School of Medicine, Nankai University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Wei+X%22">Wei X</searchLink>; School of Medicine, Nankai University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.; Medical School of Chinese PLA, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; School of Medicine, Nankai University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.; Medical School of Chinese PLA, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Li+F%22">Li F</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Jing+Y%22">Jing Y</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Bo+J%22">Bo J</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Dou+L%22">Dou L</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Liu+D%22">Liu D</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Gu+Z%22">Gu Z</searchLink>; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Gao+C%22">Gao C</searchLink>; School of Medicine, Nankai University, Tianjin, China.; Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2026 Feb; Vol. 67 (3), pp. 685-698. <i>Date of Electronic Publication: </i>2026 Jan 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41489116
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2025.2605516
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 685
    Titles:
      – TitleFull: Clinical outcomes of modified busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for T-cell acute lymphoblastic leukemia/lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Guo J
      – PersonEntity:
          Name:
            NameFull: Li M
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Zhang Q
      – PersonEntity:
          Name:
            NameFull: Wang N
      – PersonEntity:
          Name:
            NameFull: Wei Y
      – PersonEntity:
          Name:
            NameFull: Wei X
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Li F
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Jing Y
      – PersonEntity:
          Name:
            NameFull: Bo J
      – PersonEntity:
          Name:
            NameFull: Dou L
      – PersonEntity:
          Name:
            NameFull: Liu D
      – PersonEntity:
          Name:
            NameFull: Gu Z
      – PersonEntity:
          Name:
            NameFull: Gao C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2026 Feb
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1